 |
 Video: What is a Stock Split?
|
|
|
| Geron is a biopharmaceutical company that is focused on the development and commercialization of imetelstat, a telomerase inhibitor. Co. is conducting two ongoing Phase 3 clinical trials that are designed to enable registration of imetelstat: (i) IMerge Phase 3 in lower risk myelodysplastic syndromes (MDS), and (ii) IMpactMF in refractory myelofibrosis (MF). Imetelstat has been granted Fast Track designations by the U.S. Food and Drug Administration for the treatment of patients with transfusion-dependent anemia due to lower risk MDS and who are refractory or resistant to treatment with an erythropoiesis stimulating agent and for the treatment of patients with MF. According to our GERN split history records, Geron has had 1 split. | |
|
Geron (GERN) has 1 split in our GERN split history database. The split for GERN took place on July 22, 2014. This was a 1058 for 1000 split, meaning for each 1000 shares of GERN owned pre-split, the shareholder now owned 1058 shares. For example, a 1000 share position pre-split, became a 1058 share position following the split.
When a company such as Geron splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the GERN split history from start to finish, an original position size of 1000 shares would have turned into 1058 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Geron shares, starting with a $10,000 purchase of GERN, presented on a split-history-adjusted basis factoring in the complete GERN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$2.07 |
|
| End price/share: |
$3.69 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
78.26% |
|
| Average Annual Total Return: |
5.95% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$17,824.18 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 07/22/2014 | 1058 for 1000 |
|
|
Free GERN Email Alerts:
